Neuronetics gets FDA approval for anti-depression device

10/8/2008 | Philadelphia Inquirer, The

The FDA has approved Neuronetics' NeuroStar TMS Therapy, a "transcranial magnetic stimulation" therapy system for use in treating depression. The device will be offered to patients who failed to respond to other anti-depression therapies and will be available initially in a few treatment centers in the U.S., the company said.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ